Companies › LSTA

Lisata Therapeutics Inc (LSTA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000320017 · EDGAR filings · Updated 2026-07-28

Lisata Therapeutics Inc (LSTA) has reported institutional ownership of 11.7%, with 35 institutional managers holding positions valued at $5.27M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — SC TO-T/A filed
• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — SC 14D9/A filed
• 2026-07-17 — Current report (8-K) filed
• 2026-07-17 — SC 14D9/A filed
• 2026-07-17 — SC TO-T/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Lisata Therapeutics Inc has 35 institutional holders and institutional ownership of 11.7%.

Insider activity

Insiders reported 25 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

IN8BIO INC (INAB) · ESTRELLA IMMUNOPHARMA INC (ESLA) · ACTINIUM PHARMACEUTICALS INC (ATNM) · PAVmed Inc (PAVM) · MINDWALK HOLDINGS CORP COM (HYFT) · Marker Therapeutics Inc (MRKR)